3rd Quarter - Report

WILLIAMS AND JENSEN, PLLC for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, Lower Costs, More Cures Act of 2021 and H.R. 5376, "Inflation Reduction Act of 2022" (PL 117-169). Policies impacting U.S. address to the Covid-19 pandemic. General education about policies to improve health care outcomes for sickle cell disease.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & ofc VA 7; Sr Policy Adv, Majority Leader, Rep E Cantor; Sr Policy Adv, Republican Whip, Rep E Cantor; Sr Policy Adv, Majority Whip, Rep R Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C. Cox

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (117th), H.R. 5376 (117th), H.R. 19 (117th)

Medical/Disease Research/Clinical Labs MED

General education about FDA approval policies and NIH research activities. H.R. 7667, the Food and Drug Amendments of 2022. S.4348, the FDA Safety and Landmark Act. H.R.6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180), including FDA User Fee Reauthorization Act of 2022.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & ofc VA 7; Sr Policy Adv, Majority Leader, Rep E Cantor; Sr Policy Adv, Republican Whip, Rep E Cantor; Sr Policy Adv, Majority Whip, Rep R Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C. Cox

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6833 (117th), S. 4348 (117th), H.R. 7667 (117th)

Medicare/Medicaid MMM

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, Lower Costs, More Cures Act of 2021 and H.R. 5376, "Inflation Reduction Act of 2022" (PL 117-169). Policies impacting U.S. address to the Covid-19 pandemic.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & ofc VA 7; Sr Policy Adv, Majority Leader, Rep E Cantor; Sr Policy Adv, Republican Whip, Rep E Cantor; Sr Policy Adv, Majority Whip, Rep R Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C. Cox

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3 (117th), H.R. 5376 (117th), H.R. 19 (117th)

Taxation/Internal Revenue Code TAX

Orphan drug tax credit issues and general business tax issues.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER Sch. C, Treasury; Associate Staff, House Rules Committee; LD, Rep. Scott McInnis
CHERYL LYNN JAEGER Shd employee, Ofc of the Speaker 7 Ofc of VA 7; Sr. Policy Adv, Maj Leader, Rep Cantor; Sr. Policy Adv, Rep Whip, Rep Cantor; Sr. Policy Adv, Maj Whip, Rep Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C. Cox

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Policies impacting U.S. address to the Covid-19 pandemic. General education about policies to improve health care outcomes for sickle cell disease.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep Cantor; Sr. Policy Adv, Republican Whip, Rep Cantor; Sr Policy Adv, Majority Whip, Rep Blunt; Prof Staff House Committee on E&C; Sr. LA to Rep Cox

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.